Transplant Diagnostic Market (Screening - Pre-Transplant Diagnostic, Post-Transplant Diagnostic; Technique - Molecular Assay, Non-Molecular Assay; Application - Stem Cell Transplantation, Solid Organ Transplantation (Kidney, Liver, Heart, Lungs, Pancreas, Small Bowel); Product and Services - Reagents and Consumables, Instruments, Software; End user - Hospital and Transplant Centers, Research Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 - 2030

Description

Transplant Diagnostic Market – Snapshot

The global transplant diagnostic market is expanding due to the increasing number of patients emphasizing on early patient profiling during organ transplantation and rising adoption of transplant diagnostic techniques. The global transplant diagnostic market was valued at US$ 730.9 Mn in 2017 and is projected to surpass US$ 1,289.3 Mn by 2026, expanding at a compound annual growth rate (CAGR) of more than 6.5% from 2018 to 2026. The global market is expanding at a relatively higher growth rate owing to increasing bone marrow transplantation practices, high incidences of pediatric transplantation surgery, occurrence of kidney disorder among geriatric population, and increasing clinical evidence to establish clinical efficacy of molecular assay technique.

Transplant diagnostic is an administrative as well as clinical tool that helps improve operational efficiency of transplantation technique. Transplant diagnostic aids the patients suffering from cancer in order to improve overall operational efficiency as well as patient care. High prevalence and incidence rates of kidney dysfunction, cardiac diseases, increase in number of cases of lungs disorder and orthopedic injuries in the global population has led to the increase in patient flow to private clinics and hospitals. These factors, collectively, are projected to drive the demand for transplant diagnostic in the near future. Furthermore, the compatibility of markers increases the probability of graft survival and decreases severe immunologic transplant complications, which in turn is estimated to fuel the transplant diagnostic market in the near future.

The global transplant diagnostic market has been broadly segmented based on screening, technique, product & services, application, end-user, and region. In terms of application, the global market has been categorized into stem cell transplantation and solid organ transplantation. The solid organ transplantation segment has been further sub-segmented into kidney, liver, heart, lungs, pancreas, and small bowel. The kidney transplant sub-segment accounted for a key share of the solid organ transplantation segment, in terms of revenue, of the global market in 2017. The liver sub-segment is estimated to expand at a prominent growth rate during the forecast period, and the sub-segment is estimated to report significant gain in market share by the end of 2026. Liver transplant diagnostic is increasingly gaining popularity among cancer patients and physicians, which is also a major factor that is estimated to drive the liver sub-segment between 2018 and 2026.

In terms of technique, the global transplant diagnostic has been classified into molecular assay and non-molecular assay. The non-molecular assay segment dominated the global market and is likely to maintain its dominance by the end of 2026 with marginal increase in its year-on-year growth rate. Rapid advances in the fields of transplant medicine and cancer treatment and the ever-growing implementation of immunomodulatory regimens led to significant increase in the prevalence and prolonged survival of people in immunocompromised states. These are key factors which have led the non-molecular assay segment to hold a prominent share of the global market. Based on screening, the transplant diagnostic market has been bifurcated into pre-transplant diagnostic and post-transplant diagnostic. In terms of product & services, the transplant diagnostic market has been split into reagents & consumables, instruments, and software. Based on end-user, the global market has been segregated into hospital & transplant centers, research laboratories, and others.

In terms of region, the global transplant diagnostic market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market and is projected to lose market share by the end of 2026. The market in North America is primarily driven by the rapid increase in geriatric population, high adoption rate of transplantation technique for cancer, and rise in incidence of kidney disorders among geriatric population in the U.S. Moreover, increasing awareness programs about transplantation by pharmaceutical companies is a major practice witnessed in the U.S., which is projected to fuel the transplant diagnostic market in the U.S. during the forecast period. The market in Asia Pacific is expected to expand at a rapid pace during the forecast period. China dominated the transplant diagnostic market in Asia Pacific, whereas the market in India is estimated to expand at a significant CAGR during the forecast period.

Companies such as Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., and Becton, Dickinson and Company accounted for a major share of the global transplant diagnostic market in 2017 In July 2017, Thermo Fisher Scientific acquired Linkage Biosciences. Linkage Biosciences is presently a part of Thermo Fisher's transplant diagnostics business. Through this acquisition, Thermo Fisher currently provides services to more than 1,000 transplant centres in more than 60 countries. Other global players operating in the market include Ortho Clinical Diagnostics (a part of Carlyle Group), Immucor, Inc., Illumina, Inc., Siemens Healthineers (Siemens AG), and Agilent Technologies. Companies are adopting the strategy of acquisition and collaboration with parallel companies in order to improve and strengthen its geographic presence in the global market.

The global transplant diagnostic market has been segmented as given below:

Screening

  • Pre-Transplant Diagnostic
  • Post-Transplant Diagnostic

Technique

  • Molecular Assay
  • Non-Molecular Assay

Application

  • Solid Organ Transplantation
  • Kidney
  • Liver
  • Heart
  • Lungs
  • Pancreas
  • Small Bowel
  • Stem Cell Transplantation

Product & Services

  • Reagents & Consumables
  • Instruments
  • Software & Services

End-user

  • Hospitals
  • Clinics
  • Rehab centers
  • Others

Region

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC countries
  • South Africa
  • Israel
  • Rest of Middle East & Africa

TABLE OF CONTENT

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Transplant Diagnostic Market

4. Market Overview
     4.1. Introduction
            4.1.1. Technique Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunity
            4.3.4. Trends
     4.4. Global Transplant Diagnostic Market Analysis and Forecast, 2016–2026
            4.4.1. Market Revenue Projections (US$ Mn)
     4.5. Market Outlook
     4.6.Regulatory Scenarios
     4.7. Number of Transplantations, by Region/Country
     4.8. Key Success Factors of Top 3 Companies

5. Global Transplant Diagnostic Market Analysis and Forecast, by Technique
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Global Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
            5.3.1. Molecular Assay
            5.3.2. Non-Molecular Assay
     5.4. Market Attractiveness, by Technique

6. Global Transplant Diagnostic Market Analysis and Forecast, by Application
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Global Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            6.3.1. Solid Organ Transplantation
                     6.3.1.1. Kidney
                     6.3.1.2. Liver
                     6.3.1.3. Heart
                     6.3.1.4. Lungs
                     6.3.1.5. Pancreas
                     6.3.1.6. Small Bowel
            6.3.2. Stem Cell Transplantation
     6.4. Market Attractiveness, by Application

7. Global Transplant Diagnostic Market Analysis and Forecast, by Screening
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Global Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
            7.3.1. Pre-Transplant Diagnostic
            7.3.2. Post-Transplant Diagnostic
            7.3.3. Instruments
     7.4. Market Attractiveness, by Screening

8. Global Transplant Diagnostic Market Analysis and Forecast, by Product & Services
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Global Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            8.3.1. Reagents & Consumables
            8.3.2. Instruments
            8.3.3. Software & Services
     8.4. Market Attractiveness, by Product & Services

9. Global Transplant Diagnostic Market Analysis and Forecast, by End-user
     9.1. Introduction & Definition
     9.2. Key Findings / Developments
     9.3. Global Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
            9.3.1. Hospital & Transplant Centers
            9.3.2. Research Laboratories
            9.3.3. Others
     9.4. Market Attractiveness, by End-user

10. Global Transplant Diagnostic Market Analysis and Forecast, by Region
     10.1.Key Findings
     10.2. Global Transplant Diagnostic Market Value Forecast, by Region
            10.2.1. North America
            10.2.2. Europe
            10.2.3. Asia Pacific
            10.2.4. Latin America
            10.2.5. Middle East & Africa
     10.3.Market Attractiveness, by Country/Region

11. North America Transplant Diagnostic Market Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
     11.2. North America Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
            11.2.1. Molecular Assay
            11.2.2. Non-Molecular Assay
     11.3. North America Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
            11.3.1. Solid Organ Transplantation
                     11.3.1.1. Kidney
                     11.3.1.2. Liver
                     11.3.1.3. Heart
                     11.3.1.4. Lungs
                     11.3.1.5. Pancreas
                     11.3.1.6. Small Bowel
            11.3.2. Stem Cell Transplantation
     11.4. North America Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
            11.4.1. Pre-Transplant Diagnostic
            11.4.2. Post-Transplant Diagnostic
            11.4.3. Instruments
     11.5. North America Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            11.5.1. Reagents & Consumables
            11.5.2. Instruments
            11.5.3. Software & Services
     11.6. North America Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
            11.6.1. Hospital & Transplant Centers
            11.6.2. Research Laboratories
            11.6.3. Others
     11.7. North America Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
            11.7.1. U.S.
            11.7.2. Canada
     11.8. North America Transplant Diagnostic Market Attractiveness Analysis
            11.8.1. By Technique
            11.8.2. By Application
            11.8.3. By Screening
            11.8.4. By Product & Services
            11.8.5. By End-user
            11.8.6. By Country

12. Europe Transplant Diagnostic Market Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
     12.2. Europe Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
            12.2.1. Molecular Assay
            12.2.2. Non-Molecular Assay
     12.3. Europe Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
            12.3.1. Solid Organ Transplantation
                     12.3.1.1. Kidney
                     12.3.1.2. Liver
                     12.3.1.3. Heart
                     12.3.1.4. Lungs
                     12.3.1.5. Pancreas
                     12.3.1.6. Small Bowel
            12.3.2. Stem Cell Transplantation
     12.4. Europe Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
            12.4.1. Pre-Transplant Diagnostic
            12.4.2. Post-Transplant Diagnostic
            12.4.3. Instruments
     12.5. Europe Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            12.5.1. Reagents & Consumables
            12.5.2. Instruments
            12.5.3. Software & Services
     12.6. Europe Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
            12.6.1. Hospital & Transplant Centers
            12.6.2. Research Laboratories
            12.6.3. Others
     12.7. Europe Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
            12.7.1. Germany
            12.7.2. U.K.
            12.7.3. France
            12.7.4. Spain
            12.7.5. Italy
            12.7.6. Rest of Europe
     12.8. Europe Transplant Diagnostic Market Attractiveness Analysis
            12.8.1. By Technique
            12.8.2. By Application
            12.8.3. By Screening
            12.8.4. By Product & Services
            12.8.5. By End-user
            12.8.6. By Country

13. Asia Pacific Transplant Diagnostic Market Analysis and Forecast
     13.1.Introduction
            13.1.1. Key Findings
     13.2. Asia Pacific Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
            13.2.1. Molecular Assay
            13.2.2. Non-Molecular Assay
     13.3. Asia Pacific Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
            13.3.1. Solid Organ Transplantation
                     13.3.1.1. Kidney
                     13.3.1.2. Liver
                     13.3.1.3. Heart
                     13.3.1.4. Lungs
                     13.3.1.5. Pancreas
                     13.3.1.6. Small Bowel
            13.3.2. Stem Cell Transplantation
     13.4. Asia Pacific Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
            13.4.1. Pre-Transplant Diagnostic
            13.4.2. Post-Transplant Diagnostic
            13.4.3. Instruments
     13.5. Asia Pacific Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            13.5.1. Reagents & Consumables
            13.5.2. Instruments
            13.5.3. Software & Services
     13.6. Asia Pacific Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
            13.6.1. Hospital & Transplant Centers
            13.6.2. Research Laboratories
            13.6.3. Others
     13.7. Asia Pacific Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
            13.7.1. China
            13.7.2. Japan
            13.7.3. India
            13.7.4. Australia & New Zealand
            13.7.5. Rest of Asia Pacific
     13.8. Asia Pacific Transplant Diagnostic Market Attractiveness Analysis
            13.8.1. By Technique
            13.8.2. By Application
            13.8.3. By Screening
            13.8.4. By Product & Services
            13.8.5. By End-user
            13.8.6. By Country

14. Latin America Transplant Diagnostic Market Analysis and Forecast
     14.1.Introduction
            14.1.1. Key Findings
     14.2. Latin America Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
            14.2.1. Molecular Assay
            14.2.2. Non-Molecular Assay
     14.3. Latin America Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
            14.3.1. Solid Organ Transplantation
                     14.3.1.1. Kidney
                     14.3.1.2. Liver
                     14.3.1.3. Heart
                     14.3.1.4. Lungs
                     14.3.1.5. Pancreas
                     14.3.1.6. Small Bowel
            14.3.2. Stem Cell Transplantation
     14.4. Latin America Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
            14.4.1. Pre-Transplant Diagnostic
            14.4.2. Post-Transplant Diagnostic
            14.4.3. Instruments
     14.5. Latin America Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            14.5.1. Reagents & Consumables
            14.5.2. Instruments
            14.5.3. Software & Services
     14.6. Latin America Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
            14.6.1. Hospital & Transplant Centers
            14.6.2. Research Laboratories
            14.6.3. Others
     14.7. Latin America Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
            14.7.1. Brazil
            14.7.2. Mexico
            14.7.3. Rest of Latin America
     14.8. Latin America Transplant Diagnostic Market Attractiveness Analysis
            14.8.1. By Technique
            14.8.2. By Application
            14.8.3. By Screening
            14.8.4. By Product & Services
            14.8.5. By End-user
            14.8.6. By Country

15. Middle East & Africa Transplant Diagnostic Market Analysis and Forecast
     15.1.Introduction
            15.1.1. Key Findings
     15.2. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
            15.2.1. Molecular Assay
            15.2.2. Non-Molecular Assay
     15.3. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
            15.3.1. Solid Organ Transplantation
                     15.3.1.1. Kidney
                     15.3.1.2. Liver
                     15.3.1.3. Heart
                     15.3.1.4. Lungs
                     15.3.1.5. Pancreas
                     15.3.1.6. Small Bowel
            15.3.2. Stem Cell Transplantation
     15.4. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
            15.4.1. Pre-Transplant Diagnostic
            15.4.2. Post-Transplant Diagnostic
            15.4.3. Instruments
     15.5. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            15.5.1. Reagents & Consumables
            15.5.2. Instruments
            15.5.3. Software & Services
     15.6. Middle East & Africa Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
            15.6.1. Hospital & Transplant Centers
            15.6.2. Research Laboratories
            15.6.3. Others
     15.7. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
            15.7.1. GCC countries
            15.7.2. South Africa
            15.7.3. Israel
            15.7.4. Rest of Middle East & Africa
     15.8. Middle East & Africa Transplant Diagnostic Market Attractiveness Analysis
            15.8.1. By Technique
            15.8.2. By Application
            15.8.3. By Screening
            15.8.4. By Product & Services
            15.8.5. By End-user
            15.8.6. By Country

16. Competition Landscape
     16.1.Market Player – Competition Matrix (by Tier and Size of companies)
     16.2.Market Share Analysis by Company (2017)
     16.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            16.3.1. Bio-Rad Laboratories, Inc.
                     16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.1.2. Product Portfolio
                     16.3.1.3. SWOT Analysis
                     16.3.1.4. Financial Overview
                     16.3.1.5. Strategic Overview
            16.3.2. Qiagen N.V.
                     16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.2.2. Product Portfolio
                     16.3.2.3. SWOT Analysis
                     16.3.2.4. Financial Overview
                     16.3.2.5. Strategic Overview
            16.3.3. F. Hoffmann-La Roche AG
                     16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.3.2. Product Portfolio
                     16.3.3.3. SWOT Analysis
                     16.3.3.4. Financial Overview
                     16.3.3.5. Strategic Overview
            16.3.4. Thermo Fisher Scientific, Inc.
                     16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.4.2. Product Portfolio
                     16.3.4.3. SWOT Analysis
                     16.3.4.4. Financial Overview
                     16.3.4.5. Strategic Overview
            16.3.5. Becton, Dickinson and Company
                     16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.5.2. Product Portfolio
                     16.3.5.3. SWOT Analysis
                     16.3.5.4. Financial Overview
                     16.3.5.5. Strategic Overview
            16.3.6. Ortho Clinical Diagnostics
                     16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.6.2. Product Portfolio
                     16.3.6.3. SWOT Analysis
                     16.3.6.4. Financial Overview
                     16.3.6.5. Strategic Overview
            16.3.7. Immucor, Inc.
                     16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.7.2. Product Portfolio
                     16.3.7.3. SWOT Analysis
                     16.3.7.4. Financial Overview
                     16.3.7.5. Strategic Overview
            16.3.8. Illumina, Inc.
                     16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.8.2. Product Portfolio
                     16.3.8.3. SWOT Analysis
                     16.3.8.4. Financial Overview
                     16.3.8.5. Strategic Overview
            16.3.9. Siemens Healthineers (Siemens AG)
                     16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.9.2. Product Portfolio
                     16.3.9.3. SWOT Analysis
                     16.3.9.4. Financial Overview
                     16.3.9.5. Strategic Overview
            16.3.10. Agilent Technologies
                     16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.10.2. Product Portfolio
                     16.3.10.3. SWOT Analysis
                     16.3.10.4. Financial Overview
                     16.3.10.5. Strategic Overview
            16.3.11. Others

Delivery Format : EXCEL/Data Pack

Choose License Type

Checkout Inquiry Sample